TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.